NCI

Practice Area: 
Stock Symbol: 
NCI
Case Status: 
Investigations

Ademi & O’Reilly, LLP is investigating Navigant (NYSE: NCI) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Navigant to Veritas.

Ademi & O’Reilly, LLP alleges Navigant’s financial outlook is improving and yet shareholders will receive only $28 in cash for each share of Navigant common stock they own.  Veritas is acquiring Navigant at a substantial discount.  The merger agreement unreasonably limits competing bids for Navigant by prohibiting solicitation of further bids, and imposing a termination penalty if Navigant accepts a superior bid. Navigant insiders will receive millions of dollars as part of change of control arrangements. We are investigating on the conduct of Navigant’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Navigant.